Alzchem Group Ag (ALZCF) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Alzchem Group Ag.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.716 Yeah, good day, ladies and gentlemen, and warm welcome to today's Bionics Call of the 00:00:04.716 -- 00:00:09.642 Ice Young Group AG, following the publication of the Q1 figures of 2025. 00:00:09.642 -- 00:00:11.524 I'm delighted 00:00:11.524 -- 00:00:16.710 to welcome the CEO, Andreas Niedermeyer, CFO, Andreas Ljusler, as well as 00:00:16.710 -- 00:00:22.256 CSO, Dr. Georg Weichselbaumer, who will speak in a moment and guide us through the presentation 00:00:22.256 -- 00:00:27.402 and the results. After the presentation, we will move forward with the Q&A session, 00:00:27.402 -- 00:00:33.384 and with this, let's start. Mr. Niedermayer, the stage is yours. 00:00:33.384 -- 00:00:37.009 Yes, thank you for the warm introduction. Good morning together. 00:00:37.009 -- 00:00:42.477 Thank you for joining us today, and welcome to our first quarterly call. 00:00:42.477 -- 00:00:47.204 For that year, as always, we will go through the presentation first, and then we'll be 00:00:47.204 -- 00:00:50.970 available for questions at the end. 00:00:50.970 -- 00:00:56.779 Let's skip the disclaimer and the first 00:00:56.779 -- 00:01:01.947 slides here. And directly start with the highlights. 00:01:01.947 -- 00:01:06.998 So the highlights presented here reflect the robust performance of the Alskim 00:01:06.998 -- 00:01:12.168 Group in quarter one. We are seeing strong development trends in the specialty 00:01:12.168 -- 00:01:17.278 chemical segment in particular, which made a significant contribution to our 00:01:17.278 -- 00:01:22.423 sales and EBITDA figures here. So in the area of the free cash flow, we grew 00:01:22.423 -- 00:01:24.125 disproportionately 00:01:24.125 -- 00:01:30.031 due to initial customer payments in connection with our capacit...